Medical Research

18 year follow up study suggests high mortality risk from untreated sleep disordered breathing

Moderate-to-severe sleep apnea is independently associated with increased risk of mortality

Treatment of obstructive sleep apnea with CPAP may lower cardiovascular risk

CPAP treatment decreases auto accidents in sleep apnea sufferers


A study found 16% of Australian commercial drivers suffer from obstructive sleep apnea and 60% have sleep-disordered breathing.

Read more about sleep disordered breathing.

New Products

S8 AutoSet Spirit™ II
Premium APAP device. Now with Easy-Breathe technology.

S8 Elite™ II
Premium CPAP device. Now with Easy-Breathe technology.

Mirage Activa™ LT
Experience the laws of attraction.

S8 Escape™ II
Standard CPAP device. Now with Easy-Breathe technology.

Swift™ LT
Light touch, Easy fit.

VPAP™ IV ST
Non-invasive bi-level pressure support. Compact, high performance.

News and Events

ResMed Inc. announces record financial results for the quarter ended September 30, 2008



News Release

ResMed supports IDF recommendations

International Diabetes Federation (IDF) makes statement supporting reciprocal screening of all patients with type 2 diabetes or sleep apnea.

Learn more about the link between OSA and type 2 diabetes.

Improving therapy

To get the most out of your treatment, read our FAQs.

ResMed is a leading developer, manufacturer, and marketer of products for the diagnosis and treatment of sleep-disordered breathing.

This page was last updated on: 7-11-2008